240 related articles for article (PubMed ID: 28876533)
1. Multi-objective Optimization of Benzamide Derivatives as Rho Kinase Inhibitors.
Cardoso Gajo G; Rodrigues Silva D; Barigye SJ; da Cunha EFF
Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28876533
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a novel ROCK2 inhibitor with anti-migration effects via docking and high-content drug screening.
Chong CM; Kou MT; Pan P; Zhou H; Ai N; Li C; Zhong HJ; Leung CH; Hou T; Lee SM
Mol Biosyst; 2016 Aug; 12(9):2713-21. PubMed ID: 27354305
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent and selective urea-based ROCK inhibitors: Exploring the inhibitor's potency and ROCK2/PKA selectivity by 3D-QSAR, molecular docking and molecular dynamics simulations.
Mei D; Yin Y; Wu F; Cui J; Zhou H; Sun G; Jiang Y; Feng Y
Bioorg Med Chem; 2015 May; 23(10):2505-17. PubMed ID: 25882521
[TBL] [Abstract][Full Text] [Related]
5. Development and design of novel cardiovascular therapeutics based on Rho kinase inhibition-In silico approach.
Ćirić Zdravković S; Pavlović M; Apostlović S; Koraćević G; Šalinger Martinović S; Stanojević D; Sokolović D; Veselinović AM
Comput Biol Chem; 2019 Apr; 79():55-62. PubMed ID: 30716601
[TBL] [Abstract][Full Text] [Related]
6. 3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase.
Aouidate A; Ghaleb A; Ghamali M; Ousaa A; Choukrad M; Sbai A; Bouachrine M; Lakhlifi T
Comput Biol Chem; 2018 Jun; 74():201-211. PubMed ID: 29635214
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.
Oluić J; Nikolic K; Vucicevic J; Gagic Z; Filipic S; Agbaba D
Comb Chem High Throughput Screen; 2017 Aug; 20(4):292-303. PubMed ID: 28460621
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling-driven approach for identification of Janus kinase 1 inhibitors through 3D-QSAR, docking and molecular dynamics simulations.
Itteboina R; Ballu S; Sivan SK; Manga V
J Recept Signal Transduct Res; 2017 Oct; 37(5):453-469. PubMed ID: 28537140
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling studies of Rho kinase inhibitors using molecular docking and 3D-QSAR analysis.
Qin J; Lei B; Xi L; Liu H; Yao X
Eur J Med Chem; 2010 Jul; 45(7):2768-76. PubMed ID: 20347188
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of urea-based ROCK2 inhibitors.
Wang L; Qi J; Fan M; Yao L
Chem Biol Drug Des; 2021 Dec; 98(6):969-978. PubMed ID: 34581498
[TBL] [Abstract][Full Text] [Related]
11. An integrated molecular modeling approach for in silico design of new tetracyclic derivatives as ALK inhibitors.
Peddi SR; Sivan SK; Manga V
J Recept Signal Transduct Res; 2016 Oct; 36(5):488-504. PubMed ID: 26758803
[TBL] [Abstract][Full Text] [Related]
12. 4D-QSAR and MIA-QSAR study on the Bruton's tyrosine kinase (Btk) inhibitors.
Ma W; Wang Y; Chu D; Yan H
J Mol Graph Model; 2019 Nov; 92():357-362. PubMed ID: 31450065
[TBL] [Abstract][Full Text] [Related]
13. Discovery of bis-aryl urea derivatives as potent and selective Limk inhibitors: Exploring Limk1 activity and Limk1/ROCK2 selectivity through a combined computational study.
Cui J; Ding M; Deng W; Yin Y; Wang Z; Zhou H; Sun G; Jiang Y; Feng Y
Bioorg Med Chem; 2015 Dec; 23(23):7464-77. PubMed ID: 26545798
[TBL] [Abstract][Full Text] [Related]
14. Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.
Martin E; Mukherjee P
J Chem Inf Model; 2012 Jan; 52(1):156-70. PubMed ID: 22133092
[TBL] [Abstract][Full Text] [Related]
15. Consensus scoring model for the molecular docking study of mTOR kinase inhibitor.
Li DD; Meng XF; Wang Q; Yu P; Zhao LG; Zhang ZP; Wang ZZ; Xiao W
J Mol Graph Model; 2018 Jan; 79():81-87. PubMed ID: 29154212
[TBL] [Abstract][Full Text] [Related]
16. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
17. Molecular Dynamics Guided Receptor Independent 4D QSAR Studies of Substituted Coumarins as Anticancer Agents.
Patil R; Sawant S
Curr Comput Aided Drug Des; 2015; 11(1):39-50. PubMed ID: 26081557
[TBL] [Abstract][Full Text] [Related]
18. Discovery and optimization of triazine derivatives as ROCK1 inhibitors: molecular docking, molecular dynamics simulations and free energy calculations.
Shen M; Zhou S; Li Y; Pan P; Zhang L; Hou T
Mol Biosyst; 2013 Mar; 9(3):361-74. PubMed ID: 23340525
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Rho-kinase inhibitors by docking-based virtual screening.
Shen M; Yu H; Li Y; Li P; Pan P; Zhou S; Zhang L; Li S; Lee SM; Hou T
Mol Biosyst; 2013 Jun; 9(6):1511-21. PubMed ID: 23549429
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
